Skip to main content
Premium Trial:

Request an Annual Quote

Arnold Levine, David Jackson, Jan van der Greef, Victor Dzau, Marc Kirschner, Douglas Lauffenburger, Christopher Sander, Richard Dondero, Laura Francis, Elenie Chadbourne, Kathleen Grim, Tracey Wielinski

Premium

Beyond Genomics of Waltham Mass., has appointed members to its newly formed research and development advisory board: Arnold Levine, a professor at the Cancer Institute of New Jersey and the former president of Rockefeller University, and Jeffrey Friedman, a professor at Rockefeller University, will be co-chairs of the board. The other members are

David Jackson, Jan van der Greef, Victor Dzau, Marc Kirschner, Douglas Lauffenburger,

and Christopher Sander.


Richard Dondero has become vice president for research and development at New Brunswick, NJ-based Senesco Technologies. Most recently, he was a group leader in the proteomics reagent manufacturing arm of Molecular Staging. Dondero holds an MS in biology from Seton Hall University in South Orange, NJ, and a BA in biology/chemistry from New Jersey City University.


Laura Francis will leave her post as chief financial officer and treasurer of Bruker BioSciences for personal reasons and “to pursue other interests,” Bruker said on Thursday. She will retain her current position until Sept. 1 to help ensure a smooth transition. Bruker said it will start searching for a new CFO, to be based at its Billerica, Mass., headquarters.


Oscient Pharmaceuticals of Waltham, Mass., formerly Genome Therapeutics, has appointed three new vice presidents. Elenie Chadbourne has become vice president for drug safety and pharmacovigilance, joining the company from Genzyme. Kathleen Grim is the company’s new vice president for regulatory affairs. She comes to Oscient from Millennium Pharmaceuticals. Tracey Wielinski has joined Oscient as vice president of corporate qual-ity and compliance. Most recently, she worked at Abbott Laboratories’ MediSense business group.

The Scan

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.